Galapagos NV (GLPG) has released an update.
Galapagos NV shared positive first quarter financial results for 2024, with net revenues rising to €62.4 million, a 7% increase from the previous year, and a significant turnaround to a net profit from continuing operations of €23.5 million. The company has streamlined its operations by transferring its Jyseleca business to Alfasigma and is focusing on expanding its R&D pipeline through strategic collaborations and investments in oncology and immunology. Galapagos is maintaining its cash burn guidance and actively pursuing business development opportunities to strengthen its market position.
For further insights into GLPG stock, check out TipRanks’ Stock Analysis page.
